checkAd
    Startseite > Aktien > AC Immune > Nachrichten
    AC Immune Aktie
    2,1900
     
    EUR
    +2,34 %
    +0,0500 EUR
    Letzter Kurs 26.04.24 Tradegate
    2,1450
     
    EUR
    780 STK
    Geldkurs 26.04.24
    2,2400
     
    EUR
    750 STK
    Briefkurs 26.04.24
    ISIN: CH0329023102 · WKN: A2AR5F · SYM: IMR · Schweiz

    Neueste Nachrichten

    AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
    14.03.24 · globenewswire · AC Immune
    AC Immune Announces Upcoming Presentations at AD/PD 2024
    22.02.24 · globenewswire · AC Immune
    AC Immune to Regain Global Rights to Crenezumab and Semorinemab
    22.01.24 · globenewswire · AC Immune
    AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
    03.01.24 · globenewswire · AC Immune
    AC Immune Announces Pricing of Underwritten Offering of Common Shares
    15.12.23 · globenewswire · AC Immune
    AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
    15.12.23 · globenewswire · AC Immune
    AC Immune to Present at the Jefferies 2023 London Healthcare Conference
    07.11.23 · globenewswire · AC Immune
    AC Immune: Meilensteine voraus - finanziert bis Ende 2024
    03.11.23 · 4investors · AC Immune
    AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
    03.11.23 · globenewswire · AC Immune
    AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023
    02.11.23 · globenewswire · AC Immune
    AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
    27.10.23 · globenewswire · AC Immune
    AC Immune Announces Upcoming Presentations at the 16th CTAD Conference
    17.10.23 · globenewswire · AC Immune